Advanced Biliary Tract Carcinoma clinical trials

Explore recruiting advanced biliary tract carcinoma clinical trials.

Recruiting advanced biliary tract carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Biliary Tract Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TACTIC : MP0317, A TUMOR TARGETING FAP DEPENDENT CD40 AGONIST DARPIN, IN COMBINATION WITH CHEMOIMMUNOTHERAPY IN FIRST LINE TREATMENT FOR PATIENTS WITH ADVANCED BILIARY TRACT CARCINOMA A RANDOMIZED NON COMPARATIVE PROOF OF CONCEPT PHASE II STUDY

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Biliary Tract Carcinoma trials by city

Advanced Biliary Tract Carcinoma clinical trials

Recruiting advanced biliary tract carcinoma studies right now

AB122 Platform Study

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Agnostic Therapy in Rare Solid Tumors

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Also recruiting in Europe

TACTIC : MP0317, A TUMOR TARGETING FAP DEPENDENT CD40 AGONIST DARPIN, IN COMBINATION WITH CHEMOIMMUNOTHERAPY IN FIRST LINE TREATMENT FOR PATIENTS WITH ADVANCED BILIARY TRACT CARCINOMA A RANDOMIZED NON COMPARATIVE PROOF OF CONCEPT PHASE II STUDY

Advanced Biliary Tract Carcinoma trials by city

Other conditions